REG - Bellevue Healthcare - Notification of Board Changes

Bellevue Healthcare TrustAnnouncement

23/04/2025 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250423:nRSW9240Fa&default-theme=true

RNS Number : 9240F  Bellevue Healthcare Trust PLC  23 April 2025

Bellevue Healthcare Trust plc

(the "Company")

Notification of Board Changes

The Company announces that Mr Randeep Grewal and Mr Paul Southgate, who have
served on the Board since the launch of the Company in December 2016, have
today retired from the Board.

Ms Kate Bolsover, who joined the Board in July 2021, has been appointed
Chairman of the Board with immediate effect.

Ms Clare Brady, who joined the Board in February 2025, has today been
appointed as Chairman of the Audit and Risk Committee, with Ms Jo Dixon
remaining on the Board as Senior Independent Director until the 2026 AGM. Ms
Sarah MacAulay was also appointed in February 2025 to further strengthen the
Board.

The Board is engaged in an ongoing search with a head-hunter for another
suitable independent non-executive director, who will succeed Jo Dixon upon
her retirement at the AGM in 2026. The Board is cognisant that they need to
appoint a Parker Review compliant individual and will provide further updates
in due course.

LEI: 213800HQ3J3H9YF2UI82

Enquiries:

NSM Funds (UK) Limited

Company Secretary

bellevue@nsm.group (mailto:bellevue@nsm.group)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAKLDAEESEFA